<rss version="2.0" 
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
>

<channel>
	<title>News on Drug Development Scotland Limited from BioPortfolio.com</title>
	<link>http://www.BioPortfolio.com</link>
	<description>Consolidated Drug Development Scotland Limited news from BioPortfolio.com</description>
	<pubDate>Wed, 10 Feb 2010 09:22:00 GMT</pubDate>
	<language>en</language>
<atom:link href="http://www.bioportfolio.co.uk/cgi-bin/rssnews.pl?q=Drug+Development+Scotland+Limited" rel="self" type="application/rss+xml" />

	
<item><title>Xcite Energy Limited ('Xcite Energy' or the 'Company') Key Role for AMEC in Bentley Field Development</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4040283&amp;HITNO=0&amp;MSIZE=77&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Drug%20Development%20Scotland%20Limited&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4040283&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2538687236%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4040283&amp;HITNO=0&amp;MSIZE=77&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Drug%20Development%20Scotland%20Limited&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4040283&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2538687236%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Genetic Engineering News:</description></item>
<item><title>Focusing on Depression in Expectant and New Fathers</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4024662&amp;HITNO=1&amp;MSIZE=77&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Drug%20Development%20Scotland%20Limited&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4024662&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2529048856%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4024662&amp;HITNO=1&amp;MSIZE=77&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Drug%20Development%20Scotland%20Limited&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4024662&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2529048856%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Psychiatric Times:</description></item>
<item><title>PRESS DIGEST - British business - Feb 4</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4010471&amp;HITNO=2&amp;MSIZE=77&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Drug%20Development%20Scotland%20Limited&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4010471&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2522475697%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4010471&amp;HITNO=2&amp;MSIZE=77&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Drug%20Development%20Scotland%20Limited&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4010471&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2522475697%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Reuters India:</description></item>
<item><title>PRESS DIGEST - British business - Feb 4</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4010307&amp;HITNO=3&amp;MSIZE=77&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Drug%20Development%20Scotland%20Limited&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4010307&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2522357316%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4010307&amp;HITNO=3&amp;MSIZE=77&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Drug%20Development%20Scotland%20Limited&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4010307&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2522357316%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Reuters UK:</description></item>
<item><title>Syntropharma Signs US Marketing and Distribution Agreement with Ranbaxy for Generic Transdermal Product</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4014202&amp;HITNO=4&amp;MSIZE=77&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Drug%20Development%20Scotland%20Limited&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4014202&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2523925659%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4014202&amp;HITNO=4&amp;MSIZE=77&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Drug%20Development%20Scotland%20Limited&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4014202&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2523925659%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Pharma Live:</description></item>
<item><title>Daiichi Sankyo Initiates Largest Single, Double-Blind, Randomized, Phase III Trial For Treatment Of Recurrent</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4012628&amp;HITNO=5&amp;MSIZE=77&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Drug%20Development%20Scotland%20Limited&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4012628&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2523484456%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4012628&amp;HITNO=5&amp;MSIZE=77&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Drug%20Development%20Scotland%20Limited&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4012628&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2523484456%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Medical News Today:</description></item>
<item><title>Daiichi Sankyo Initiates Largest Single, Double-Blind, Randomized, Phase III Trial for Treatment and Preventio</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4010037&amp;HITNO=6&amp;MSIZE=77&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Drug%20Development%20Scotland%20Limited&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4010037&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2522204538%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4010037&amp;HITNO=6&amp;MSIZE=77&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Drug%20Development%20Scotland%20Limited&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4010037&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2522204538%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Pharmacy Choice:</description></item>
<item><title>Month Ahead Company Events</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4007992&amp;HITNO=7&amp;MSIZE=77&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Drug%20Development%20Scotland%20Limited&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4007992&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2521372533%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4007992&amp;HITNO=7&amp;MSIZE=77&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Drug%20Development%20Scotland%20Limited&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4007992&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2521372533%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Murray Income Trust:</description></item>
<item><title>Peakdale Molecular Partners With Pfizer</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4007288&amp;HITNO=8&amp;MSIZE=77&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Drug%20Development%20Scotland%20Limited&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4007288&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2521069107%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4007288&amp;HITNO=8&amp;MSIZE=77&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Drug%20Development%20Scotland%20Limited&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4007288&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2521069107%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Drug Discovery and Development:</description></item>
<item><title>PFE Sandwich</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4003597&amp;HITNO=9&amp;MSIZE=77&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Drug%20Development%20Scotland%20Limited&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4003597&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2519600555%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4003597&amp;HITNO=9&amp;MSIZE=77&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Drug%20Development%20Scotland%20Limited&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4003597&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2519600555%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>BioFind:</description></item>
<item><title>Daiichi Sankyo Initiates Largest Single, Double-Blind, Randomized, Phase III Trial for Treatment and Prevention of Recurrent Venous Thromboembolism</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4007935&amp;HITNO=10&amp;MSIZE=77&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Drug%20Development%20Scotland%20Limited&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4007935&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2521342829%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4007935&amp;HITNO=10&amp;MSIZE=77&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Drug%20Development%20Scotland%20Limited&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4007935&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2521342829%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>SmartBrief:</description></item>
<item><title>MagIndustries Conference Call Notice on PDF Agreement With COMPLANT</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3995567&amp;HITNO=11&amp;MSIZE=77&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Drug%20Development%20Scotland%20Limited&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3995567&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2515745192%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3995567&amp;HITNO=11&amp;MSIZE=77&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Drug%20Development%20Scotland%20Limited&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3995567&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2515745192%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Genetic Engineering News:</description></item>
<item><title>Syntropharma Signs US Marketing and Distribution Agreement with Ranbaxy for Generic Transdermal Product</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3991440&amp;HITNO=12&amp;MSIZE=77&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Drug%20Development%20Scotland%20Limited&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3991440&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2513707817%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3991440&amp;HITNO=12&amp;MSIZE=77&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Drug%20Development%20Scotland%20Limited&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3991440&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2513707817%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>BioPortfolio:</description></item>
<item><title>MagIndustries Signs Project Development Framework Agreement With COMPLANT</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3990931&amp;HITNO=13&amp;MSIZE=77&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Drug%20Development%20Scotland%20Limited&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3990931&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2513494755%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3990931&amp;HITNO=13&amp;MSIZE=77&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Drug%20Development%20Scotland%20Limited&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3990931&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2513494755%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Genetic Engineering News:</description></item>
<item><title>H2O Innovation and Chembond Chemicals Sign Joint Venture Agreement-Create H2O Innovation India to Serve Indust</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3990924&amp;HITNO=14&amp;MSIZE=77&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Drug%20Development%20Scotland%20Limited&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3990924&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2513492505%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3990924&amp;HITNO=14&amp;MSIZE=77&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Drug%20Development%20Scotland%20Limited&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3990924&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2513492505%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Genetic Engineering News:</description></item>
</channel></rss>